Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 2, 2020
Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine CancerYunfei Wen, Ying Wang, Anca Chelariu-Raicu, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2019
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II StudyBrittany Knick Ragon, Olatoyosi Odenike, Maria R Baer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
The Journal of Urology|November 17, 2007
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancerWassim Kassouf, Peter C Black, Tomasz Tuziak, et al.
Oncotarget|June 5, 2018
ADH1B promotes mesothelial clearance and ovarian cancer infiltrationKshipra M Gharpure, Olivia D Lara, Yunfei Wen, et al.
Ebiomedicine|September 11, 2016
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical UseVipulkumar Dadhania, Miao Zhang, Li Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M Aparicio, Li Shen, Elsa Li Ning Tapia, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AMLShelley Herbrich, Natalia Baran, Tianyu Cai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 2, 2017
Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South TexasJingjing Jiao, Weibo Niu, Ying Wang, et al.
Gynecologic Oncology|May 22, 2017
Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approachSusan K Lutgendorf, Eileen Shinn, Jeanne Carter, et al.
Pageof 5